The purpose of this study was to evaluate the prevalence of carrier thalassemia on pregnant women population who visit to antenatal clinic Hasan Sadikin Hospital, Bandung, Indonesia. Design study was cross sectional that 219 blood samples have collected in tubes containing EDTA anticoagulant. Sample examined for routine blood analysis and OTOFT method. If OTOFT method result was positive that confirm with alkaline Hemoglobin electrophoresis. 17 (7.76%) suspected carrier thalassemia were positive OTOFT method. Samples with OTOFT method positive have average values of Hemoglobin, MCV, and MCH were 10.88±1.61 g/dL, 82.64±8.66 fL, and 26.42±3.99 pg, that less than negative OTOFT method group. Average concentration of HbA2 Alkaline electrophoresis was 5.4%, more than common normal value could be concluded suspected carrier ? thalassemia. Population of suspected carrier thalassemia was 7.76%. Combination MCV, MCH value and OTOFT method can use as simple screening tool for detection thalassemia trait in primary level.
___
1. Cunningham FG LK, Bloom SL, Spong CY, Dashe JS, Hoffman BL. Williams Obstetrics. 24th edition. New York: McGraw Hill; 2014.
2. Renzo Galanello R, Raff A. Review Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11
3. Sarnaik SA. Thalassemia and related hemoglobinopathies. Indian J Pediatr. 2005;72(4):319-24.
4. Forget B, Cohen A. Thalassemia syndrome. In: Hoffman R, Benz E, Shattil S, Furie B, Cohen H, McGlave P, eds, Hematology Basic Principles and Practice. 4 edition. Philadelphia: Elsevier; 2005;557-89.
5. Moghaddam ZK, Bayat N, Valaei A, Kordafshari A, Zarbakhsh B, Zeinali S, Karimipoor M. Co-inheritance of ?-and ?-thalassemia: challenges in prenatal diagnosis of thalassemia. IJBC. 2012;2:81-84.
6. Bianchi N, Borgatti M, Gambari R. Gene silencing in thalassemia. Minerva Biotec. 2008;20:51-5.
7. Cohen A, Galanelo R, Pennel D, Cunningham M, Vichinsky E. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004:14-34.
8. Forget B, Cohen A. Thalassemia syndrome. In: Hoffman R, Benz E, Shattil S, Furie B, Cohen H, McGlave P, eds, Hematology Basic Principles and Practice. 4 edition. Philadelphia: Elsevier; 2005;557-89.
9. Setianingsih I, Harahap A, Nainggolan I. Phenotypes and molecular defect. In: Marzuki, Verhoef, Snippe, eds, Alpha Thalassemia in Indonesia. New York: Kluwer academic. 2003;47-56.
10.Ritu R, Pushpa C. Evaluation of NESTROFT as a screening test for ? thalassemia trait. J Advance Researches in Biological Sciences.2013;5(2):127- 30
11. Tangvarasittichai O, Jeenapongsa R, Sitthiworanan C, Sanguansermsri T. Diagnostic value of combined parameters for ?-thalassemia-1 screening in pregnant women. Naresuan University Journal. 2004;12(2):19.
12. Thomas P, Oni L, Alli M, Hilaire J, Smith A, Leavey C, Banarsee R. Antenatal screening for haemoglobinopathies in primary care: a whole system participatory action research project. Br J Gen Pract. 2005;55(515):424-8.
13.Chow J,Phelan L,Bain BJ. Evaluation of Single-Tube Osmotic Fragility as a Screening Test for Thalassemia. Am J Hematol. 2005;79(3):198-201.
14. Iswari S, Williamson R, Marzuki S, Harahap A, Tamam M, Forrest S. Molecular basis of ?-Thalassemia in Indonesia: application to Prenatal Diagnosis. Mol Diag. 1998;3:11-20.
15. Sanchaisuriya K, Fucharoen S, Fucharoen G, Ratanasiri T, Sanchaisuriya P, Changtrakul Y, Ukosanakarn U, Ussawaphark W, Schelp FP. A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy. Am J Clin Pathol. 2005;123(1):113-8.
16. Eldor A, Rachmilewitz EA. The hypercoable state in thalassemia. Blood J. 2002;99(1):36-43.
17. Taher AT, Otrock ZK, Uthman I, Cappellini MD. Thalassemia and hypercoagulability. Blood Rev. 2008; 22(5): 283-92.
18. Wiwanitkit V, Suwansaksri J, Paritpokee N. Combined one-tube osmotic fragility (OF) test and dichlorophenol-indolphenol (DCIP) test screening for hemoglobin disorders, an experience in 213 Thai pregnant women. Clin Lab. 2002;48(9-10):525-8.